• About
    • Overview
    • Leadership
    • Board of Directors
  • Technology
    • Overview
    • Breath Sampler
    • Spectrometer
    • Publications
  • News
  • Careers
  • Contact
Breathe BioMedical
  • About
    • Overview
    • Leadership
    • Board of Directors
  • Technology
    • Overview
    • Breath Sampler
    • Spectrometer
    • Publications
  • News
  • Careers
  • Contact

Early disease detection
could be as easy as breathing.

We are on a mission to revolutionize early cancer detection with our innovative breath analytics platform technology.

Our primary focus is to develop a breath test to be used as an adjunct to mammography screening to detect early-stage breast cancer in women with dense breast tissue.

Women who have dense breast tissue are four to five times more likely to develop breast cancer and the sensitivity of screening mammography can be as low as 30% in women with extremely dense breast tissue.

Results of Breathe BioMedical Inc.’s most recent research supports the potential of our technology. Our study identified differences in the breath signatures of women with early-stage breast cancer compared to those without breast cancer with 88.2% accuracy. A sub-group analysis found that breast tissue density had no significant effect on accuracy.

Early breast cancer detection saves lives. Our technology could make early detection easier, faster and more accessible than ever before.

Just breathe®

Learn More

Groundbreaking
Publications

  • Document 2023 ASCO Breast Cancer Abstract
  • Document 2022 ASCO Breast Cancer Abstract
  • Document Journal of Breath Research Paper
  • Document ASCO Lung Cancer Abstract
  • Image View Breath Biopsy Poster

Breast Cancer Detection

Implementing our innovative breath test as an adjunct to mammography screening for women with dense breast tissue has the potential to find more cancer sooner.

Learn More

The Science of Breath Analytics

Breath analytics has the potential to play a pivotal role in early disease detection and improving outcomes by detecting health issues before symptoms appear.

Learn More

The Leaders Making it Happen

Breathe BioMedical’s leadership team has decades of experience in developing and commercializing medtech and diagnostics innovations.

Learn More

Biomarkers in Breath

There’s much more in exhaled breath than most realize. Find out more about how our breath analytics technology may change how and when disease can be detected.

Learn More

In the News

Breathe BioMedical Launches Multi-Center Clinical Trial of its Breath Test for Breast Cancer at George Washington University Breast Center

Read More »

Breathe BioMedical Inc. to Present at Centurion One Capital 8th Annual Growth Conference

Read More »

Breathe BioMedical Announces Dr. Rachel Brem as Chief Medical Officer

Read More »

Breathe BioMedical Announces Bill Dawes as CEO

Read More »

Pivot Magazine – Out of Breath

Read More »

Radio-Canada – A new tool, developed in Moncton, could revolutionize cancer screening

Read More »

Drug Discovery News

Drug Discovery News – Don’t Hold Your Breath

Read More »

  • Home
  • About
  • Leadership
  • Technology
  • News
  • Contact
  • Careers
  • ISO 13485
  • Privacy Notice
Breathe BioMedical

Breathe BioMedical Headquarters

191 Halifax Street
Moncton, NB E1C 9R6
T: +1-506-855-2400
E: info@breathebiomedical.com

Breathe BioMedical Inc.

245 Main Street, 2nd Floor
Cambridge, MA 02142
T: +1-617-203-2089

© 2025 Breathe BioMedical® | All Rights Reserved

We use cookies to ensure that we give you the best experience on our website. By using our website, you agree to our use of cookies.Ok